Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.71 $19.54 Wednesday, 8th May 2024 MGNX stock ended at $14.66. This is 8.66% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 14.66% from a day low at $13.71 to a day high of $15.72.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Feb 28, 2023 $5.97 $6.15 $5.88 $6.09 383 772
Feb 27, 2023 $6.22 $6.39 $5.83 $5.98 440 089
Feb 24, 2023 $6.19 $6.40 $5.85 $6.17 513 419
Feb 23, 2023 $6.68 $7.19 $6.19 $6.31 1 237 297
Feb 22, 2023 $6.32 $6.79 $6.28 $6.55 907 968
Feb 21, 2023 $6.54 $6.80 $6.23 $6.24 795 953
Feb 17, 2023 $5.39 $6.81 $5.32 $6.61 2 894 708
Feb 16, 2023 $4.71 $5.43 $4.71 $5.26 807 498
Feb 15, 2023 $5.17 $5.17 $4.73 $4.82 730 043
Feb 14, 2023 $6.21 $6.21 $4.53 $5.24 3 050 014
Feb 13, 2023 $5.49 $6.43 $5.34 $6.35 1 049 922
Feb 10, 2023 $5.59 $5.65 $5.49 $5.51 327 805
Feb 09, 2023 $5.58 $5.90 $5.51 $5.65 552 960
Feb 08, 2023 $5.71 $5.75 $5.49 $5.53 365 216
Feb 07, 2023 $5.79 $5.85 $5.61 $5.71 275 631
Feb 06, 2023 $5.56 $6.07 $5.48 $5.79 610 944
Feb 03, 2023 $5.70 $5.95 $5.47 $5.59 571 166
Feb 02, 2023 $5.92 $6.09 $5.79 $5.92 342 464
Feb 01, 2023 $5.79 $6.00 $5.67 $5.95 363 142
Jan 31, 2023 $5.62 $5.86 $5.58 $5.77 559 843
Jan 30, 2023 $5.70 $5.73 $5.48 $5.62 372 320
Jan 27, 2023 $5.90 $6.00 $5.70 $5.74 388 040
Jan 26, 2023 $6.39 $6.46 $5.82 $5.92 349 440
Jan 25, 2023 $6.13 $6.34 $5.94 $6.22 452 039
Jan 24, 2023 $6.04 $6.42 $6.03 $6.23 598 059
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT